Patent+disputes | search
Click here to view Patent+disputes news from 60+ newspapers.
Bookmark or Share- BlueBird Fails to Axe Patents in Dispute Over $2 Million DrugsA US Patent and Trademark Office administrative tribunal quashed bluebird bio Inc.'s efforts to cancel two patents its multi-million dollar drugs LentiGlobin and Zynteglo are accused of infringing.. Sloan Kettering Institute for Cancer Research’s US Patent Nos. 7,541,179 and 8,058,061 covering blood disorder treatments aren’t obvious or anticipated by prior inventions, the Patent Trial and ...
- U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug ...The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with ...
- Ten Famous Intellectual Property Disputes - Smithsonian MagazineTen Famous Intellectual Property Disputes. From Barbie to cereal to a tattoo, a copyright lawsuit can get contentious; some have even reached the Supreme Court
- Patent Dispute Report: 2023 in Review — Unified PatentsJanuary 8, 2024. Patent Dispute Report: 2023 in Review. Overview. 2023 was an eventful year for the patent world. The USPTO sought comments on the ANPRM and Patent Eligibility Restoration Act. The Unified Patent Court (UPC) launched. Pressure mounted in the EU to create a SEP commission.
- Patent litigation in the United States: overview | Practical Law - WestlawA Q&A guide to patent litigation in the United States. The Q&A gives a high-level overview of patent disputes, including sources of law; court systems; substantive law; parties to litigation; enforcement options; competition and anti-trust issues; procedure in civil courts; preliminary relief; final remedies; appeal procedure; litigation costs ...
More
